Live feed
Filing
SC 13D
SC 13D0000903423-18-000570·Allogene Therapeutics, Inc.
Schedule 13D ownership disclosure
Allogene Therapeutics Inc
Security class unavailable · CUSIP: 019770106
Event date: 2018-10-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 23,135,061
- Percent of class
- 19.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-18-000570
- Form type
- SC 13D
- Filer
- Allogene Therapeutics, Inc.
- CIK
- CIK 1737287
- Filed
- Oct 25, 2018
- Reporting period
- Oct 15, 2018
- Description
- Schedule 13D beneficial ownership